Marotta Asset Management’s Genmab GMAB Stock Holding History
Bought
Maintained
Sold
Other funds holding GMAB
LWAM
VCM
JWS
GI
FFA
EWP
GWM
MGI
TFA
RWS
Marotta Asset Management's GMAB Position: Q3 2026 in Review
Marotta Asset Management reduced its Genmab (GMAB) stake by 0.66% in Q3 2026, selling an estimated $2.37K and leaving 11,352 shares worth $405K. The position accounts for 0.07% of the portfolio, ranked #71.
Marotta Asset Management first reported a position in GMAB in Q1 2021 and has held it in 22 quarters since. The position peaked at $745K in Q3 2021. 13 funds tracked by Wall St. Rank hold GMAB as of Q3 2026.
- Marotta Asset Management held 11,352 shares of Genmab worth $405K as of Q3 2026.
- Marotta Asset Management sold 75 Genmab shares in Q3 2026, an estimated $2.37K.
- Genmab made up 0.07% of Marotta Asset Management's portfolio in Q3 2026, its #71 holding.
- Marotta Asset Management first reported a position in Genmab in Q1 2021 and has held it in 22 quarters since.
- Marotta Asset Management's Genmab position peaked at $745K in Q3 2021.
- 13 funds tracked by Wall St. Rank held Genmab as of Q3 2026.
Based on Marotta Asset Management's 13F filing for Q3 2026, filed 2 Oct 2026.